Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

CEO & President

Chief Medical Officer

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex for the treatment of Alzheimer's disease. The company is also developing COG0201 SHINE, a randomized double-blind and placebo-controlled for mild-to-moderate AD and is in phase II clinical trial. Its product pipeline also includes CT2168 for Synucleinopathies; and CT2074 for dry age-related macular degeneration. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule thera...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-14	Premium	bought	Premium	Premium	Premium	CEO & President
2024-02-15	Premium	acquired	Premium	Premium	Premium	CEO & President
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-03	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-03	Premium	sold (taxes)	Premium	Premium	Premium	CEO & President
2023-11-08	Premium	acquired	Premium	Premium	Premium	-
2023-11-08	Premium	acquired	Premium	Premium	Premium	-
2023-06-09	Premium	acquired	Premium	Premium	Premium	-
2023-06-09	Premium	acquired	Premium	Premium	Premium	-
2023-06-09	Premium	acquired	Premium	Premium	Premium	-
2023-06-09	Premium	acquired	Premium	Premium	Premium	-
2023-06-09	Premium	acquired	Premium	Premium	Premium	-
2023-06-09	Premium	acquired	Premium	Premium	Premium	-
2023-05-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-02-03	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-02-03	Premium	acquired	Premium	Premium	Premium	CEO & President
2022-11-29	Premium	bought	Premium	Premium	Premium	-
2022-11-28	Premium	bought	Premium	Premium	Premium	-
2022-11-28	Premium	bought	Premium	Premium	Premium	-
2022-11-28	Premium	bought	Premium	Premium	Premium	-
2022-11-28	Premium	bought	Premium	Premium	Premium	-
2022-11-28	Premium	bought	Premium	Premium	Premium	-
2022-11-28	Premium	bought	Premium	Premium	Premium	-

CGTX - Cognition Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for CGTX